Your browser is no longer supported. Please, upgrade your browser.
Settings
MORF [NASD]
Morphic Holding, Inc.
Index- P/E- EPS (ttm)-2.66 Insider Own12.80% Shs Outstand36.55M Perf Week-9.18%
Market Cap1.65B Forward P/E- EPS next Y-2.96 Insider Trans-0.89% Shs Float24.91M Perf Month-31.73%
Income-91.90M PEG- EPS next Q-0.81 Inst Own72.80% Short Float3.70% Perf Quarter-29.70%
Sales16.10M P/S102.18 EPS this Y-2.20% Inst Trans1.94% Short Ratio6.15 Perf Half Y-20.64%
Book/sh9.58 P/B4.61 EPS next Y-15.00% ROA-23.30% Target Price100.50 Perf Year42.29%
Cash/sh11.49 P/C3.85 EPS next 5Y- ROE-30.30% 52W Range29.21 - 93.00 Perf YTD31.77%
Dividend- P/FCF- EPS past 5Y- ROI-32.10% 52W High-52.46% Beta-
Dividend %- Quick Ratio10.40 Sales past 5Y- Gross Margin- 52W Low51.35% ATR3.47
Employees89 Current Ratio10.40 Sales Q/Q-88.00% Oper. Margin- RSI (14)30.15 Volatility7.92% 6.77%
OptionableYes Debt/Eq0.00 EPS Q/Q-514.20% Profit Margin- Rel Volume1.82 Prev Close47.02
ShortableYes LT Debt/Eq0.00 EarningsNov 04 AMC Payout- Avg Volume149.68K Price44.21
Recom1.80 SMA20-19.57% SMA50-22.60% SMA200-23.44% Volume271,978 Change-5.98%
Oct-26-20Initiated RBC Capital Mkts Outperform $35
Jul-22-19Initiated Wells Fargo Outperform
Jul-22-19Initiated Jefferies Buy
Jul-22-19Initiated Cowen Outperform
Jul-22-19Initiated BMO Capital Markets Outperform $30
Nov-16-21 09:00AM  
Nov-15-21 09:05AM  
Nov-04-21 06:35PM  
04:05PM  
11:19AM  
Nov-01-21 03:01PM  
Oct-29-21 11:38AM  
Oct-25-21 11:37AM  
Oct-12-21 04:05PM  
Sep-15-21 10:48AM  
Sep-01-21 08:00AM  
Aug-24-21 06:19AM  
Aug-23-21 04:01PM  
Aug-04-21 09:05AM  
07:00AM  
Aug-02-21 03:01PM  
Jul-19-21 06:19PM  
Jul-09-21 10:37AM  
06:35AM  
Jul-05-21 06:18AM  
Jul-02-21 09:00AM  
Jun-03-21 01:57AM  
May-28-21 08:00AM  
07:30AM  
May-05-21 02:05AM  
Apr-29-21 09:55AM  
08:00AM  
Apr-28-21 04:01PM  
12:33PM  
Apr-27-21 04:15AM  
Apr-14-21 06:50AM  
Apr-12-21 08:00AM  
Mar-02-21 08:25PM  
11:25AM  
08:01AM  
Mar-01-21 04:01PM  
01:33PM  
08:15AM  
07:00AM  
06:55AM  
06:30AM  
Feb-22-21 08:00AM  
Feb-16-21 04:05PM  
Feb-09-21 03:13AM  
Jan-05-21 08:00AM  
Dec-30-20 08:00AM  
Dec-15-20 07:42AM  
Dec-09-20 01:53PM  
Dec-04-20 08:00AM  
Nov-17-20 09:05AM  
Nov-11-20 06:50AM  
Nov-09-20 07:00AM  
Nov-05-20 10:40AM  
Oct-12-20 07:00AM  
Sep-28-20 10:01AM  
Sep-23-20 06:30AM  
Sep-21-20 04:45PM  
Sep-03-20 04:30PM  
Aug-25-20 08:38AM  
06:30AM  
Aug-10-20 08:35AM  
07:00AM  
Aug-07-20 03:34PM  
Aug-03-20 12:31PM  
Jun-29-20 07:30AM  
Jun-18-20 08:00AM  
Jun-15-20 09:36PM  
May-27-20 08:00AM  
May-06-20 04:05PM  
Apr-29-20 04:15PM  
Apr-07-20 08:00AM  
Mar-17-20 08:00AM  
Feb-28-20 08:00AM  
Feb-27-20 04:05PM  
Feb-14-20 11:29AM  
Jan-08-20 12:00PM  
Nov-30-19 09:40AM  
Nov-18-19 04:15PM  
Nov-12-19 04:24PM  
Oct-30-19 10:35AM  
Aug-30-19 01:00PM  
Aug-12-19 06:30AM  
Jul-17-19 09:00AM  
Jul-01-19 04:30PM  
Jun-26-19 08:30PM  
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a47-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and MORF-720 and MORF-627, which is in the preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing av1 for the treatment of fibrotic diseases, and av8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrodinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is based in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farrell Robert E JrSVP Finance and CAONov 03Option Exercise4.3210,00043,20020,000Nov 03 07:15 PM
SCHEGERIN MARCCFO and COONov 01Option Exercise15.005,47782,15512,003Nov 03 07:13 PM
SCHEGERIN MARCCFO and COONov 01Sale60.005,477328,6206,526Nov 03 07:13 PM
SCHEGERIN MARCCFO and COOOct 26Option Exercise15.00375556,563Oct 28 07:02 PM
SCHEGERIN MARCCFO and COOOct 26Sale60.00372,2206,526Oct 28 07:02 PM
Rogers BruceChief Scientific OfficerOct 19Option Exercise4.3213,00056,160102,905Oct 21 06:59 PM
SCHEGERIN MARCCFO and COOOct 15Option Exercise15.003,33850,0709,864Oct 15 07:00 PM
SCHEGERIN MARCCFO and COOOct 15Sale60.003,338200,2806,526Oct 15 07:00 PM
SCHEGERIN MARCCFO and COOOct 14Option Exercise15.0024,184362,76030,710Oct 15 07:00 PM
SCHEGERIN MARCCFO and COOOct 14Sale60.0224,1841,451,4466,526Oct 15 07:00 PM
SCHEGERIN MARCCFO and COOOct 13Option Exercise15.001,96429,4608,490Oct 15 07:00 PM
SCHEGERIN MARCCFO and COOOct 13Sale60.001,964117,8456,526Oct 15 07:00 PM
Linde PeterChief Medical OfficerSep 16Sale66.514,000266,03711,272Sep 17 07:04 PM
Rogers BruceChief Scientific OfficerSep 13Option Exercise4.321,7217,43591,626Sep 13 07:04 PM
Farrell Robert E JrSVP Finance and CAOSep 13Sale65.013,049198,20210,000Sep 14 07:08 PM
Rogers BruceChief Scientific OfficerSep 13Sale65.001,721111,87389,905Sep 13 07:04 PM
Farrell Robert E JrSVP Finance and CAOSep 10Option Exercise4.324,97421,48822,908Sep 14 07:08 PM
Rogers BruceChief Scientific OfficerSep 10Option Exercise4.328,27935,76598,184Sep 13 07:04 PM
Farrell Robert E JrSVP Finance and CAOSep 10Sale65.149,859642,16613,049Sep 14 07:08 PM
Rogers BruceChief Scientific OfficerSep 10Sale65.118,279539,07889,905Sep 13 07:04 PM
Rogers BruceChief Scientific OfficerSep 09Option Exercise4.3230,000129,600119,905Sep 13 07:04 PM
Rogers BruceChief Scientific OfficerSep 09Sale60.9730,0001,829,09389,905Sep 13 07:04 PM
SPRINGER TIMOTHY ADirectorAug 20Buy56.7911,620659,944912,241Aug 20 07:08 PM
SPRINGER TIMOTHY ADirectorAug 19Buy56.5233,0001,865,010900,621Aug 20 07:08 PM
SPRINGER TIMOTHY ADirectorAug 18Buy55.7030,3071,688,202867,621Aug 20 07:08 PM
Farrell Robert E JrSVP Finance and CAOJun 18Option Exercise4.3220086418,134Jun 21 07:04 PM
Farrell Robert E JrSVP Finance and CAOJun 18Sale65.0020013,00017,934Jun 21 07:04 PM
Farrell Robert E JrSVP Finance and CAOJun 16Option Exercise4.323001,29618,234Jun 21 07:04 PM
Farrell Robert E JrSVP Finance and CAOJun 16Sale65.0030019,50117,934Jun 21 07:04 PM
Farrell Robert E JrSVP Finance and CAOJun 14Option Exercise4.323,52615,23221,460Jun 14 07:55 PM
Farrell Robert E JrSVP Finance and CAOJun 14Sale65.003,526229,20017,934Jun 14 07:55 PM
Farrell Robert E JrSVP Finance and CAOJun 10Option Exercise4.3216,00069,12033,934Jun 14 07:55 PM
Farrell Robert E JrSVP Finance and CAOJun 10Sale60.0816,000961,21917,934Jun 14 07:55 PM
Linde PeterChief Medical OfficerJun 01Sale49.856,000299,1104,600Jun 03 07:15 PM
SPRINGER TIMOTHY ADirectorMay 26Buy46.9725,0001,174,300837,314May 26 07:02 PM
SPRINGER TIMOTHY ADirectorMay 25Buy45.8765,0002,981,381812,314May 26 07:02 PM
SPRINGER TIMOTHY ADirectorMay 24Buy46.5140,0001,860,311747,314May 26 07:02 PM
SPRINGER TIMOTHY ADirectorMay 21Buy45.50232,29510,569,422707,314May 25 07:03 PM
Nashat AmirDirectorMay 21Sale45.50232,29510,569,422136,691May 25 07:20 PM
Omega Fund V, L.P.DirectorApr 30Sale55.149,487523,0752,068,913May 03 03:12 PM
Omega Fund V, L.P.DirectorApr 29Sale54.057,671414,5872,078,400May 03 03:12 PM
Omega Fund V, L.P.DirectorApr 28Sale55.713,366187,5362,086,071Apr 29 12:09 PM
Omega Fund V, L.P.DirectorApr 27Sale55.297,338405,7182,089,437Apr 29 12:09 PM
Omega Fund V, L.P.DirectorApr 26Sale56.555,146290,9932,096,775Apr 27 10:13 AM
Omega Fund V, L.P.DirectorApr 23Sale55.678,672482,7752,101,921Apr 27 10:13 AM
Omega Fund V, L.P.DirectorApr 22Sale57.5512,235704,0752,110,593Apr 23 01:28 PM
Omega Fund V, L.P.DirectorApr 21Sale56.307,552425,1862,122,828Apr 23 01:28 PM
Omega Fund V, L.P.DirectorApr 20Sale54.449,793533,1622,130,380Apr 21 10:36 AM
Omega Fund V, L.P.DirectorApr 19Sale54.128,081437,3442,140,173Apr 21 10:36 AM
Omega Fund V, L.P.DirectorApr 16Sale54.786,565359,6312,148,254Apr 19 01:32 PM
Omega Fund V, L.P.DirectorApr 15Sale56.1211,181627,4902,154,819Apr 19 01:32 PM
Omega Fund V, L.P.DirectorApr 14Sale57.5213,932801,3712,166,000Apr 15 10:57 AM
Omega Fund V, L.P.DirectorApr 13Sale57.427,004402,1362,179,932Apr 15 10:57 AM
Omega Fund V, L.P.DirectorApr 12Sale57.2814,592835,7842,186,936Apr 13 11:33 AM
Omega Fund V, L.P.DirectorApr 09Sale59.0310,220603,2602,201,528Apr 13 11:33 AM
Omega Fund V, L.P.DirectorApr 08Sale60.8215,236926,7192,211,748Apr 09 11:18 AM
Omega Fund V, L.P.DirectorApr 07Sale60.7411,449695,3652,226,984Apr 09 11:18 AM
Omega Fund V, L.P.DirectorApr 06Sale61.1210,881665,0112,238,433Apr 07 02:01 PM
Omega Fund V, L.P.DirectorApr 05Sale62.119,543592,6792,249,314Apr 07 02:01 PM
Omega Fund V, L.P.DirectorApr 01Sale65.0013,621885,3142,258,857Apr 02 10:33 AM
Omega Fund V, L.P.DirectorMar 31Sale63.0716,7841,058,6192,272,478Apr 02 10:33 AM
Omega Fund V, L.P.DirectorMar 30Sale61.4819,9081,223,9152,289,262Mar 31 04:35 PM
Omega Fund V, L.P.DirectorMar 29Sale58.8616,168951,6522,309,170Mar 31 04:35 PM
Omega Fund V, L.P.DirectorMar 26Sale59.7412,981775,4582,325,338Mar 29 10:58 AM
Omega Fund V, L.P.DirectorMar 25Sale58.2834,9562,037,0642,338,319Mar 29 10:58 AM
Omega Fund V, L.P.DirectorMar 24Sale59.5132,9711,962,1922,373,275Mar 25 10:51 AM
Omega Fund V, L.P.DirectorMar 23Sale62.2419,3431,203,8642,406,246Mar 25 10:51 AM
Omega Fund V, L.P.DirectorMar 22Sale64.889,153593,8162,425,589Mar 23 02:53 PM
Omega Fund V, L.P.DirectorMar 19Sale63.4516,6291,055,1742,434,742Mar 23 02:53 PM
Omega Fund V, L.P.DirectorMar 18Sale63.8819,4721,243,9042,451,371Mar 19 11:52 AM
Omega Fund V, L.P.DirectorMar 17Sale64.2416,3811,052,3622,470,843Mar 19 11:52 AM
DeVaul WilliamGeneral Counsel and SecretaryMar 16Option Exercise4.3214,02760,59718,233Mar 17 07:05 PM
Omega Fund V, L.P.DirectorMar 16Sale64.0027,8591,782,8982,487,164Mar 17 10:16 AM
Linde PeterChief Medical OfficerMar 16Sale64.0212,000768,20110,600Mar 17 07:07 PM
DeVaul WilliamGeneral Counsel and SecretaryMar 16Sale64.0014,027897,6934,206Mar 17 07:05 PM
DeVaul WilliamGeneral Counsel and SecretaryMar 15Option Exercise4.3245,973198,60350,179Mar 17 07:05 PM
Rogers BruceChief Scientific OfficerMar 15Sale65.608,509558,18189,849Mar 17 07:09 PM
DeVaul WilliamGeneral Counsel and SecretaryMar 15Sale65.7845,9733,023,9714,206Mar 17 07:05 PM
Omega Fund V, L.P.DirectorMar 15Sale65.9036,5322,407,5732,515,023Mar 17 10:16 AM
SCHEGERIN MARCCFO and COOMar 08Buy63.503,000190,5146,379Mar 09 06:56 PM
SPRINGER TIMOTHY ADirectorMar 05Buy70.00100,0007,000,000475,019Mar 08 07:12 PM
Goyal VikasDirectorMar 05Buy70.001,00070,0001,000Mar 08 07:10 PM
Omega Fund V, L.P.DirectorMar 01Sale45.937,064324,4462,551,555Mar 01 06:14 PM
Omega Fund V, L.P.DirectorFeb 26Sale34.8219,246670,0792,558,619Mar 01 06:14 PM
Omega Fund V, L.P.DirectorFeb 25Sale33.709,679326,1822,577,865Mar 01 06:14 PM
Omega Fund V, L.P.DirectorFeb 24Sale34.772,998104,2492,587,544Feb 25 11:41 AM
Omega Fund V, L.P.DirectorFeb 23Sale33.927,550256,0642,590,542Feb 25 11:41 AM
Omega Fund V, L.P.DirectorFeb 22Sale34.916,423224,2432,598,092Feb 23 01:27 PM
Omega Fund V, L.P.DirectorFeb 19Sale35.574,436157,8012,604,515Feb 23 01:27 PM
Omega Fund V, L.P.DirectorFeb 18Sale34.938,894310,6412,608,951Feb 19 01:59 PM
Omega Fund V, L.P.DirectorFeb 17Sale35.937,262260,9242,617,845Feb 19 01:59 PM
Omega Fund V, L.P.DirectorFeb 16Sale36.586,025220,3952,625,107Feb 17 11:10 AM
Omega Fund V, L.P.DirectorFeb 12Sale37.712,36489,1532,631,132Feb 17 11:10 AM
Omega Fund V, L.P.DirectorFeb 11Sale37.764,005151,2342,633,496Feb 12 01:59 PM
Omega Fund V, L.P.DirectorFeb 10Sale37.546,068227,7822,637,501Feb 12 01:59 PM
Rogers BruceChief Scientific OfficerFeb 09Sale40.216,837274,88797,614Feb 10 07:16 PM
Omega Fund V, L.P.DirectorFeb 09Sale39.895,461217,8302,643,569Feb 10 02:27 PM
Rogers BruceChief Scientific OfficerFeb 08Sale40.034,654186,280104,451Feb 10 07:16 PM
Omega Fund V, L.P.DirectorFeb 08Sale39.5816,622657,8642,649,030Feb 10 02:27 PM
Omega Fund V, L.P.DirectorFeb 05Sale37.805,881222,2752,673,902Feb 08 02:01 PM